Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $8.93 billion. The enterprise value is $8.64 billion.
| Market Cap | 8.93B |
| Enterprise Value | 8.64B |
Important Dates
The next confirmed earnings date is Monday, July 21, 2025, after market close.
| Earnings Date | Jul 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 28.74 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Current Share Class | 28.74M |
| Shares Outstanding | 28.74M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -2.12% |
| Owned by Insiders (%) | 21.49% |
| Owned by Institutions (%) | 90.44% |
| Float | 22.54M |
Valuation Ratios
The trailing PE ratio is 23.12 and the forward PE ratio is 24.86. MEDP's PEG ratio is 3.04.
| PE Ratio | 23.12 |
| Forward PE | 24.86 |
| PS Ratio | 4.33 |
| Forward PS | 4.03 |
| PB Ratio | 15.18 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.51 |
| P/OCF Ratio | 15.34 |
| PEG Ratio | 3.04 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.79, with an EV/FCF ratio of 15.97.
| EV / Earnings | 20.75 |
| EV / Sales | 4.01 |
| EV / EBITDA | 17.79 |
| EV / EBIT | 18.93 |
| EV / FCF | 15.97 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 0.25.
| Current Ratio | 0.73 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.28 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 65.82% and return on invested capital (ROIC) is 36.25%.
| Return on Equity (ROE) | 65.82% |
| Return on Assets (ROA) | 15.44% |
| Return on Invested Capital (ROIC) | 36.25% |
| Return on Capital Employed (ROCE) | 58.88% |
| Revenue Per Employee | $365,522 |
| Profits Per Employee | $70,575 |
| Employee Count | 5,900 |
| Asset Turnover | 1.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $64.92 million in taxes.
| Income Tax | 64.92M |
| Effective Tax Rate | 13.49% |
Stock Price Statistics
The stock price has decreased by -23.35% in the last 52 weeks. The beta is 1.47, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -23.35% |
| 50-Day Moving Average | 300.79 |
| 200-Day Moving Average | 326.92 |
| Relative Strength Index (RSI) | 55.12 |
| Average Volume (20 Days) | 431,203 |
Short Selling Information
The latest short interest is 3.09 million, so 10.77% of the outstanding shares have been sold short.
| Short Interest | 3.09M |
| Short Previous Month | 3.15M |
| Short % of Shares Out | 10.77% |
| Short % of Float | 13.73% |
| Short Ratio (days to cover) | 9.55 |
Income Statement
In the last 12 months, MEDP had revenue of $2.16 billion and earned $416.39 million in profits. Earnings per share was $13.09.
| Revenue | 2.16B |
| Gross Profit | 1.47B |
| Operating Income | 456.32M |
| Pretax Income | 397.17M |
| Net Income | 416.39M |
| EBITDA | 485.51M |
| EBIT | 456.32M |
| Earnings Per Share (EPS) | $13.09 |
Balance Sheet
The company has $441.44 million in cash and $150.35 million in debt, giving a net cash position of $291.09 million or $10.13 per share.
| Cash & Cash Equivalents | 441.44M |
| Total Debt | 150.35M |
| Net Cash | 291.09M |
| Net Cash Per Share | $10.13 |
| Equity (Book Value) | 593.61M |
| Book Value Per Share | 19.94 |
| Working Capital | -300.87M |
Cash Flow
In the last 12 months, operating cash flow was $581.97 million and capital expenditures -$41.05 million, giving a free cash flow of $540.93 million.
| Operating Cash Flow | 581.97M |
| Capital Expenditures | -41.05M |
| Free Cash Flow | 540.93M |
| FCF Per Share | $18.82 |
Margins
Gross margin is 68.08%, with operating and profit margins of 21.16% and 19.31%.
| Gross Margin | 68.08% |
| Operating Margin | 21.16% |
| Pretax Margin | 22.32% |
| Profit Margin | 19.31% |
| EBITDA Margin | 22.51% |
| EBIT Margin | 21.16% |
| FCF Margin | 25.08% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 4.66% |
| FCF Yield | 6.06% |
Analyst Forecast
The average price target for MEDP is $338.90, which is 9.08% higher than the current price. The consensus rating is "Hold".
| Price Target | $338.90 |
| Price Target Difference | 9.08% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 6.93% |
| EPS Growth Forecast (5Y) | 8.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 6.7 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.7 |
| Piotroski F-Score | 5 |